Answers are grounded in this paper and cite their sources.
A patient with a history of melanoma finds prostate adenocarcinoma after unexpected fluorodeoxyglucose (FDG) uptake on routine screening positron emission tomography (PET)/CT, despite having a normal prostate-specific antigen and digital rectal examination, underscoring the necessity of secondary imaging studies to adequately screen for prostate cancer in cases of prostatic uptake on FDG PET/CT.
No takes yet. Share an insight, caveat, or question.
Schwieters et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: